Is Dogwood Therapeutics, Inc. (DWTX) a Buy, Sell, or Hold?
NASDAQ : DWTX
Dogwood Therapeutics, Inc.
$1.38 USD
$0.01 (0.73%)
- Volume
- 58.32K
- Average Volume
- 95.45K
- Market Capitalization
- $2.64M
- P/E Ratio
- -0.13
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $9.50
- Year Low
- $1.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.86
Insider Activity Summary (Last 12 Months)
Insiders Buying
30
Insiders Selling
2
Amount of Insider Selling
$2445.36
DWTX Insider Buying/Selling by Quarter
DWTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| De La Rosa Abel | director | 2026-06-16 | A-Award | 1.5 | 2026-06-17 |
| Thomas John C | director | 2026-06-16 | A-Award | 1.5 | 2026-06-17 |
| Whitley Richard James | director | 2026-06-16 | A-Award | 1.5 | 2026-06-17 |
| Keefer David R | director | 2026-06-16 | A-Award | 1.5 | 2026-06-17 |
| Grosswald Ralph | officer: SVP OF OPERATIONS | 2026-03-05 | A-Award | 2.86 | 2026-03-06 |
| Walsh Angela | officer: Chief Financial Officer | 2026-03-05 | A-Award | 2.86 | 2026-03-06 |
| Gendreau Roger Michael | officer: CHIEF MEDICAL OFFICER | 2026-03-05 | A-Award | 2.86 | 2026-03-06 |
| Duncan Gregory Scott | director, officer: CHIEF EXECUTIVE OFFICER | 2026-03-05 | A-Award | 2.86 | 2026-03-06 |
| Duncan Gregory Scott | director, officer: CHIEF EXECUTIVE OFFICER | 2025-12-04 | A-Award | 6.14 | 2025-12-05 |
| Walsh Angela | officer: Chief Financial Officer | 2025-12-04 | A-Award | 6.14 | 2025-12-05 |
| Grosswald Ralph | officer: SVP OF OPERATIONS | 2025-12-04 | A-Award | 6.14 | 2025-12-05 |
| Gendreau Roger Michael | officer: CHIEF MEDICAL OFFICER | 2025-12-04 | A-Award | 6.14 | 2025-12-05 |
| Sealbond Ltd | director, 10 percent owner, other: See Remarks | 2025-11-21 | C-Conversion | 0.0001 | 2025-11-25 |
| Sealbond Ltd | director, 10 percent owner, other: See Remarks | 2025-11-21 | C-Conversion | 0.0001 | 2025-11-25 |
| Sealbond Ltd | director, 10 percent owner, other: See Remarks | 2025-11-21 | C-Conversion | 0 | 2025-11-25 |
| Sealbond Ltd | director, 10 percent owner, other: See Remarks | 2025-11-21 | C-Conversion | 0 | 2025-11-25 |
| Gendreau Roger Michael | officer: CHIEF MEDICAL OFFICER | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| Whitley Richard James | director | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| Grosswald Ralph | officer: SVP OF OPERATIONS | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| Thomas John C | director | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| Duncan Gregory Scott | director, officer: CHIEF EXECUTIVE OFFICER | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| Keefer David R | director | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| Walsh Angela | officer: Chief Financial Officer | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| De La Rosa Abel | director | 2025-06-27 | A-Award | 4.71 | 2025-07-01 |
| Whitley Richard James | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| Whitley Richard James | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| Keefer David R | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| Keefer David R | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| Thomas John C | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| Thomas John C | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| De La Rosa Abel | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| De La Rosa Abel | director | 2025-06-18 | A-Award | 4.8 | 2025-06-23 |
| Conjoint Inc. | director, 10 percent owner, other: See Remarks | 2025-03-12 | 0 | 2025-03-20 | |
| CK Life Sciences Intl (Holdings) Inc | director, 10 percent owner, other: See Remarks | 2025-03-12 | A-Award | 0 | 2025-03-17 |
| Yu Ying Choi Alan Abel | director: | 2024-10-07 | 0 | 2024-10-17 | |
| Toh Kean Meng Melvin | director: | 2024-10-07 | 0 | 2024-10-17 | |
| Sealbond Ltd | 10 percent owner | 2024-10-07 | 0 | 2024-10-17 | |
| Sealbond Ltd | 10 percent owner | 2024-10-07 | 0 | 2024-10-17 |